首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1377357

吻合裝置市場，2028-全球產業規模、佔有率、趨勢、機會和預測，2018-2028 按產品、按應用、最終用途、地區、競爭細分。

Anastomosis Devices Market, 2028- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Application, By End-use, By Region, By Competition.

出版日期: 2023年10月03日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2022 年全球吻合器材市場價值為 31.5 億美元，預計到 2028 年預測期內將穩定成長，複合CAGR為 5.32%。多年來，醫療器材領域取得了重大進展，其中一個領域取得顯著進展的是吻合裝置的開發。吻合裝置透過促進兩條血管或中空器官（例如腸道或輸尿管）的連接以恢復正常的血流或液體通道，在外科手術中發揮至關重要的作用。這些設備已成為各種外科專業中不可或缺的工具，包括心血管、胃腸道和泌尿外科手術。

近年來，全球吻合器材市場持續成長。這種成長可歸因於多種因素，包括慢性病盛行率的增加、人口老化以及外科技術的進步。吻合裝置在涉及旁路移植、腸切除和器官移植的手術中至關重要。隨著這些手術變得越來越普遍，對有效吻合裝置的需求不斷增加。

外科縫合器廣泛用於吻合手術，提供速度和精確度。近年來，隨著人體工學設計、更好的安全功能和微創選項的發展，這些設備經歷了重大改進。傳統縫合技術在吻合中仍然必不可少，縫合材料和輸送方法也不斷創新。基於縫合的設備為外科醫生提供了更多創建安全可靠連接的選擇。這些設備旨在在兩個組織片段之間建立機械連接，從而無需縫合或釘書釘。它們在精確對準至關重要的程序中特別有價值。由於心臟病發病率的增加，心血管外科領域出現了顯著成長。血管吻合裝置在冠狀動脈繞道手術和主動脈瘤修復中至關重要。

市場概況
預測期	2024-2028
2022 年市場規模	31.5億美元
2028 年市場規模	42.9億美元
2023-2028 年CAGR	5.32%
成長最快的細分市場	醫院
最大的市場	北美洲

全球吻合器材市場可望在未來幾年持續成長。隨著手術技術變得更加複雜以及患者對微創手術的期望提高，對創新吻合裝置的需求可能會增加。此外，全球人口老化將推動對更複雜手術的需求，進一步推動市場成長。該行業還可以預期醫療設備製造商、外科醫生和研究人員之間的合作將會加強，從而開發出更先進、針對患者的解決方案。監管機構將在確保這些設備的安全性和有效性方面發揮關鍵作用。

The Global Anastomosis Devices Market has valued at USD 3.15 billion in 2022 and is anticipated to project steady growth in the forecast period with a CAGR of 5.32% through 2028. The field of medical devices has witnessed significant advancements over the years, and one area that has seen remarkable progress is the development of anastomosis devices. Anastomosis devices play a crucial role in surgical procedures by facilitating the connection of two blood vessels or hollow organs, such as the intestines or ureters, to restore normal blood flow or fluid passage. These devices have become indispensable tools in various surgical specialties, including cardiovascular, gastrointestinal, and urological procedures.

The global anastomosis devices market has experienced consistent growth in recent years. This growth can be attributed to several factors, including the increasing prevalence of chronic diseases, an aging population, and advancements in surgical techniques. Anastomosis devices are crucial in surgeries that involve bypass grafting, bowel resections, and organ transplants. As these procedures become more common, the demand for effective anastomosis devices continues to rise.

Surgical staplers are widely used in anastomosis procedures, offering speed and precision. These devices have undergone significant improvements in recent years, with the development of ergonomic designs, better safety features, and minimally invasive options. Traditional suturing techniques remain essential in anastomosis, and there have been innovations in suture materials and delivery methods. Suture-based devices provide surgeons with more options for creating secure and reliable connections. These devices are designed to create a mechanical connection between two tissue segments, eliminating the need for sutures or staples. They are particularly valuable in procedures where precise alignment is crucial. The cardiovascular surgery segment has witnessed significant growth due to the increasing incidence of heart diseases. Vascular anastomosis devices are essential in coronary artery bypass grafting and aortic aneurysm repair.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 3.15 Billion
Market Size 2028	USD 4.29 Billion
CAGR 2023-2028	5.32%
Fastest Growing Segment	Hospitals
Largest Market	North America

The global anastomosis devices market is poised for continued growth in the coming years. As surgical techniques become more sophisticated and patient expectations for minimally invasive procedures rise, the demand for innovative anastomosis devices will likely increase. Moreover, the aging global population will drive the need for more complex surgeries, further boosting market growth. The industry can also anticipate increased collaboration between medical device manufacturers, surgeons, and researchers, leading to the development of more advanced and patient-specific solutions. Regulatory bodies will play a critical role in ensuring the safety and efficacy of these devices.

Key Market Drivers

Increasing Surgical Procedures is Driving the Global Anastomosis Devices Market

The field of medical surgery has witnessed remarkable advancements over the years, with an increasing number of surgical procedures being performed worldwide. Surgical interventions have become more precise, less invasive, and more effective, leading to improved patient outcomes. One crucial aspect of many surgical procedures is the creation of anastomosis, which is the connection of two separate structures, such as blood vessels or sections of the digestive tract. As the demand for surgeries rises, so does the demand for reliable and efficient anastomosis devices.

With more surgeries being performed, the demand for anastomosis devices such as surgical staplers, sutures, and clips is on the rise. Surgeons rely on these devices to ensure secure and efficient connections between tissues and vessels. The increased demand for anastomosis devices has spurred innovation in this sector. Manufacturers are developing more advanced and user-friendly devices to meet the evolving needs of surgeons, leading to a competitive market landscape. The global anastomosis devices market is expanding its reach, with new players entering the market to cater to the growing demand. This competition is likely to drive innovation and reduce prices, making these devices more accessible. The use of advanced anastomosis devices has contributed to improved patient outcomes. Secure anastomosis reduces the risk of complications, such as leakage or infection, leading to quicker recoveries and shorter hospital stays.

The increasing number of surgical procedures performed worldwide is driving the growth of the global Anastomosis Devices Market. This trend is expected to continue as the global population ages, healthcare technology advances, and patients become more informed about their healthcare options. The development of innovative and efficient anastomosis devices plays a vital role in ensuring the success of surgical procedures and improving patient outcomes. As the demand for these devices grows, the market is likely to witness further advancements, benefiting both healthcare providers and patients alike.

Increasing Rising Chronic Diseases Fuels Growth in Global Anastomosis Devices

Chronic diseases, often referred to as non-communicable diseases (NCDs), have been on the rise globally in recent years. These conditions, which include heart disease, cancer, diabetes, and respiratory illnesses, have become a significant public health concern. As the prevalence of chronic diseases continues to increase, so does the demand for advanced medical devices and surgical techniques to treat and manage these conditions. One such area of medical innovation is the field of anastomosis devices, which play a crucial role in the treatment and recovery of patients with chronic diseases.

The world is currently facing a chronic disease epidemic. According to the World Health Organization (WHO), NCDs are the leading cause of death worldwide, responsible for approximately 71% of global deaths. The four main categories of NCDs - cardiovascular diseases, cancer, respiratory diseases, and diabetes - are responsible for the majority of these fatalities. The risk factors associated with these diseases, including poor diet, physical inactivity, tobacco use, and excessive alcohol consumption, have contributed to their increasing prevalence. Chronic diseases not only result in a significant loss of life but also pose a substantial economic burden on healthcare systems and individuals. The cost of treatment, long-term care, and lost productivity due to chronic diseases is staggering. This has prompted healthcare providers and researchers to continually seek innovative solutions to address these challenges, including the development and improvement of anastomosis devices.

Anastomosis devices are essential tools in surgical procedures aimed at treating chronic diseases. These devices enable surgeons to create secure connections between blood vessels, intestines, and other structures, restoring normal bodily functions and improving patient outcomes. The key advantages of using anastomosis devices include reduced surgery time, lower risk of complications, and faster patient recovery. These benefits are especially crucial when dealing with patients suffering from chronic conditions, as they often require multiple surgical interventions over their lifetime.

The rising incidence of chronic diseases has led to a surge in demand for anastomosis devices. The global anastomosis devices market has been experiencing steady growth, driven by factors such as technological advancements, increasing surgical procedures, and a growing aging population. Innovations in materials, design, and manufacturing techniques have improved the safety and efficacy of these devices. Furthermore, the market has seen the development of minimally invasive surgical techniques, such as laparoscopic and robotic-assisted procedures, which rely heavily on anastomosis devices. These minimally invasive approaches offer reduced scarring, shorter hospital stays, and faster recovery times, making them increasingly popular among both patients and healthcare providers.

Increasing Disposable Income is Driving the Global Anastomosis Devices Market

In recent years, the global healthcare industry has witnessed significant growth, driven by a combination of factors including advances in medical technology, increasing healthcare awareness, and rising disposable incomes. One particular segment of the healthcare market that has been experiencing substantial growth is the Anastomosis Devices Market. Anastomosis devices play a crucial role in various surgical procedures, and the demand for these devices has been on the rise, primarily due to the increasing disposable income of individuals worldwide.

Anastomosis procedures can be costly, and individuals with higher disposable incomes are more likely to opt for such surgeries when needed. As disposable income rises, more people can afford these surgical treatments, thereby increasing the demand for Anastomosis devices. Higher disposable incomes often translate into better access to advanced healthcare facilities. Patients with more financial resources can choose hospitals and healthcare providers that offer the latest surgical techniques and technologies, including Anastomosis devices. Individuals with substantial disposable income may be willing to travel to different countries for medical treatments. This has led to a global market for healthcare services, including Anastomosis procedures, benefiting device manufacturers.

Key Market Challenges

Regulatory Hurdles

One of the significant challenges faced by the Anastomosis Devices market is the stringent regulatory approval process. Regulatory bodies, such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe, have strict guidelines and requirements for medical devices' safety and efficacy. Meeting these regulatory requirements can be time-consuming and costly for manufacturers, leading to delays in product launches and increased expenses.

Lack of Skilled Surgeons

Anastomosis procedures require a high level of surgical skill and precision. However, there is a shortage of skilled surgeons in many regions, especially in developing countries. The lack of trained professionals can limit the adoption of Anastomosis Devices, as healthcare facilities may be reluctant to invest in advanced devices without qualified personnel to operate them effectively.

High Cost of Anastomosis Devices

Advanced Anastomosis Devices, such as surgical staplers and suturing devices, come with a hefty price tag. The high cost of these devices can be a significant barrier for healthcare facilities, particularly in resource-limited settings. As a result, some hospitals and clinics may opt for traditional, lower-cost methods of anastomosis, hindering market growth.

Post-Surgery Complications

Despite advancements in Anastomosis Devices, there is always a risk of post-surgery complications, such as leaks or strictures. These complications can result in patient discomfort, extended hospital stays, and increased healthcare costs. Surgeons and healthcare providers must carefully monitor patients after surgery to detect and address any potential issues promptly.

Competition and Market Saturation

The global Anastomosis Devices market is highly competitive, with several established players and new entrants vying for market share. This competition has led to product saturation in some segments, making it challenging for manufacturers to differentiate their offerings. Companies must invest in research and development to create innovative and unique devices to stay competitive in the market.

Technological Advancements

While technological advancements have driven the growth of the Anastomosis Devices market, they can also pose challenges. Rapid developments in technology mean that devices can quickly become obsolete. Manufacturers must invest in ongoing research and development to keep their products up-to-date and aligned with the latest surgical techniques and trends.

Economic Factors

Economic factors, such as fluctuations in currency exchange rates and healthcare budget constraints, can impact the purchasing power of healthcare facilities. Economic downturns and budget cuts can lead to delayed or reduced investments in medical devices, including Anastomosis Devices, affecting market growth.

Key Market Trends

Technological Advancements

In the ever-evolving landscape of healthcare, technological advancements play a pivotal role in enhancing patient outcomes and improving surgical procedures. One such field that has witnessed remarkable progress is the global Anastomosis Devices market. Anastomosis, the surgical connection of two structures, has seen a significant transformation due to innovative technological developments. These advancements have not only simplified surgical procedures but also paved the way for better patient recovery and outcomes.

One of the most significant technological advancements in the Anastomosis Devices market is the adoption of minimally invasive surgical techniques. Devices like robotic surgical systems and laparoscopic instruments have made complex anastomosis procedures more precise, less invasive, and have reduced patients' recovery times. High-resolution imaging technologies like 3D imaging, augmented reality, and intraoperative imaging systems have empowered surgeons with better visualization during procedures. This not only aids in more accurate anastomosis but also allows for real-time adjustments, ensuring the best possible outcomes. The use of advanced biomaterials and tissue engineering techniques has revolutionized anastomosis. These materials promote tissue regeneration and healing, reducing the risk of complications. Bio-absorbable staples and tissue adhesives are prime examples of such innovations. Surgical staplers have evolved significantly. Modern stapling devices come with adjustable staple heights, tissue thickness sensing, and real-time feedback systems, ensuring that each staple is placed accurately and securely. Electrosurgical instruments have gained popularity due to their precision and efficiency in creating anastomosis. These devices use electrical energy to cut and coagulate tissues, reducing bleeding and postoperative complications. Technological advancements have also expanded the reach of surgical expertise through telemedicine and remote assistance. Surgeons can now collaborate with colleagues worldwide, providing insights and guidance during complex anastomosis procedures.

The global Anastomosis Devices market is experiencing rapid growth, driven by these technological advancements. As healthcare providers and patients alike demand safer, less invasive, and more effective surgical solutions, the market is expected to continue its upward trajectory. In addition to improving patient outcomes, these advancements also have economic implications by reducing hospital stays and postoperative care costs. Furthermore, ongoing research and development in materials science, robotics, and artificial intelligence promise even more innovations in the field. These developments may lead to further refinement of anastomosis techniques, making surgery even less invasive and more precise.

Segmental Insights

Product Insights

Based on the Product, the disposable segment emerged as the dominant player in the global market for Anastomosis Devices in 2022. One of the primary advantages of disposable anastomosis devices is their role in infection control. These devices are used once and then discarded, reducing the risk of cross-contamination and healthcare-associated infections. Healthcare facilities prioritize patient safety, making disposable devices a preferred choice. While disposable devices have an upfront cost, they can be more cost-effective in the long run for healthcare providers. Reusable devices require sterilization, maintenance, and potential repairs, which can be expensive and time-consuming. Disposable devices are ready for immediate use and do not require sterilization, which can save valuable time in surgical procedures. Surgeons and medical staff can focus on patient care rather than device maintenance. Using disposable devices can reduce a healthcare facility's liability. In case of any adverse events or infections associated with reusable devices, the facility may face legal and financial consequences. Disposable devices can mitigate these risks. Over the years, disposable anastomosis devices have seen significant technological advancements, making them more efficient and user-friendly. This has contributed to their growing popularity among healthcare professionals. Disposable devices often comply with strict regulatory standards and quality control measures. Ensuring compliance with these regulations is easier with single-use devices, which can be a crucial factor in the healthcare industry. Disposable devices support the practice of preventive medicine by reducing the risk of complications and infections associated with surgical procedures. This aligns with the healthcare industry's focus on patient outcomes and safety.

Application Insights

The cardiovascular surgery segment is projected to experience rapid growth during the forecast period. Cardiovascular diseases, such as coronary artery disease and peripheral artery disease, are among the leading causes of death worldwide. These conditions often require surgical interventions, including coronary artery bypass grafting (CABG) and vascular surgeries, which involve creating connections (anastomoses) between blood vessels. The prevalence of cardiovascular diseases drives the demand for anastomosis devices. The global population is aging, leading to an increase in the number of people with cardiovascular issues. Older individuals are more likely to require surgical treatments, contributing to the growth of the cardiovascular surgery segment within the anastomosis devices market.

Regional Insights

North America emerged as the dominant player in the global Anastomosis Devices market in 2022, holding the largest market share in terms of value. North America, particularly the United States and Canada, boasts some of the most advanced healthcare infrastructures globally. This includes well-equipped hospitals, research facilities, and a highly skilled healthcare workforce. This infrastructure allows for the widespread adoption of medical devices like anastomosis devices. North America has a high healthcare expenditure per capita, which means that there is more financial capacity to invest in advanced medical technologies, including anastomosis devices. Insurance coverage and reimbursement policies in the region also play a significant role in encouraging the use of such devices. An aging population often requires more medical interventions, including surgeries that may involve the use of anastomosis devices. North America has an aging demographic, which can drive demand for these devices.

Key Market Players

Medtronic plc

LivaNova PLC

MAQUET Holding B.V. & Co. KG.

Dextera Surgical Inc.

Vitalitec Internaional Inc.

Synovis Micro Companies Alliance, Inc.

Ethicon US, LLC

Peters Surgical SASU

Report Scope:

In this report, the Global Anastomosis Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anastomosis Devices Market, By Product:

Disposable
Reusable

Anastomosis Devices Market, By Application:

Cardiovascular Surgery
Gastrointestinal Surgery
Others

Anastomosis Devices Market, By End Use:

Hospitals
Ambulatory Care Centres & Clinics

Anastomosis Devices Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anastomosis Devices Market.

Available Customizations:

Global Anastomosis Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Anastomosis Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Disposable, Reusable)
- 5.2.2. By Application (Cardiovascular Surgery, Gastrointestinal Surgery, Others)
- 5.2.3. By End-Use (Hospitals, Ambulatory Care Centers & Clinics)
- 5.2.4. By Region
- 5.2.5. By Company (2022)
5.3. Market Map

6. North America Anastomosis Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Application
- 6.2.3. By End-Use
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Anastomosis Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By End-Use
- 6.3.2. Canada Anastomosis Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By End-Use
- 6.3.3. Mexico Anastomosis Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By End-Use

7. Europe Anastomosis Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Application
- 7.2.3. By End-Use
7.3. Europe: Country Analysis
- 7.3.1. Germany Anastomosis Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By End-Use
- 7.3.2. United Kingdom Anastomosis Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By End-Use
- 7.3.3. Italy Anastomosis Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By End-Use
- 7.3.4. France Anastomosis Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By End-Use
- 7.3.5. Spain Anastomosis Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By End-Use

8. Asia-Pacific Anastomosis Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Application
- 8.2.3. By End-Use
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Anastomosis Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By End-Use
- 8.3.2. India Anastomosis Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By End-Use
- 8.3.3. Japan Anastomosis Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By End-Use
- 8.3.4. South Korea Anastomosis Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By End-Use
- 8.3.5. Australia Anastomosis Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By End-Use

9. South America Anastomosis Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Application
- 9.2.3. By End-Use
9.3. South America: Country Analysis
- 9.3.1. Brazil Anastomosis Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By End-Use
- 9.3.2. Argentina Anastomosis Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By End-Use
- 9.3.3. Colombia Anastomosis Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By End-Use

10. Middle East and Africa Anastomosis Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Application
- 10.2.3. By End-Use
10.3. MEA: Country Analysis
- 10.3.1. South Africa Anastomosis Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By End-Use
- 10.3.2. Saudi Arabia Anastomosis Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By End-Use
- 10.3.3. UAE Anastomosis Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By End-Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition
12.2. Product Development
12.3. Recent Developments

13. Global Anastomosis Devices Market: SWOT Analysis

14. Competitive Landscape

14.1. Business Overview
14.2. Application Offerings
14.3. Recent Developments
14.4. Key Personnel
14.5. SWOT Analysis
- 14.5.1. Medtronic plc
- 14.5.2. LivaNova PLC
- 14.5.3. MAQUET Holding B.V. & Co. KG.
- 14.5.4. Dextera Surgical Inc.
- 14.5.5. Vitalitec Internaional Inc.
- 14.5.6. Synovis Micro Companies Alliance, Inc.
- 14.5.7. Ethicon US, LLC
- 14.5.8. Peters Surgical SASU